SCCS OPINION ON Hydroxyapatite (nano)" - Archive ouverte HAL Accéder directement au contenu
Ouvrages Année : 2020

SCCS OPINION ON Hydroxyapatite (nano)"

U. Bernauer
  • Fonction : Auteur
Q. Chaudhry
  • Fonction : Auteur
P.J. Coenraads
  • Fonction : Auteur
M. Dusinska
  • Fonction : Auteur
E. Panteri
  • Fonction : Auteur
M. Stepnik
  • Fonction : Auteur
S. Wijnhoven
  • Fonction : Auteur
W.H. De Jong
  • Fonction : Auteur
N. Von Götz
  • Fonction : Auteur

Résumé

"SCCS OPINION ON Hydroxyapatite (nano)" SCCS/1624/20 - Preliminary Opinion U. Bernauer, L. Bodin, Q. Chaudhry, P.J. Coenraads, M. Dusinska, E. Gaffet, E. Panteri, C. Rousselle, M. Stepnik, S. Wijnhoven, W.H. de Jong, N. von Götz The SCCS adopted this document at its plenary meeting on on 27-28 October 2020 (56 Pages) Mise en ligne le 9 Novembre 2020 https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_246.pdf Conclusion of the opinion: (1) In view of the above, and taking into account the scientific data provided, does the SCCS consider the nanomaterial Hydroxyapatite safe when used in leave-on and rinse-off dermal and oral cosmetic products according to the maximum concentrations and specifications reported in the attached list, taking into account reasonably foreseeable exposure conditions? Having considered the data provided, and other relevant information available in scientific literature, the SCCS cannot conclude on the safety of the hydroxyapatite composed of rod–shaped nanoparticles (NPs) for use in oral-care cosmetic products at the maximum concentrations and specifications given in this Opinion. This is because the available data/information is not sufficient to exclude concerns over the genotoxic potential of HAP-nano. (2) Does the SCCS have any further scientific concerns with regard to the use of Hydroxyapatite in nano form in cosmetic products? Although the particle shape in the HAP-nano considered in this Opinion is reported as rod-shaped, the SCCS is aware that, depending on the manufacturing process, needle-shaped HAP nanoparticles may also be produced. The available information indicates that HAP-nano in needle-shaped form is of concern in relation to potential toxicity. Therefore, needle-shaped HAP-nano should not be used in cosmetic products. Keywords: SCCS, scientific opinion, Hydroxyapatite (nano), CAS No 1306-06-5, EC No. 215-145-20, Regulation 1223/2009 Opinion to be cited as: SCCS (Scientific Committee on Consumer Safety), Opinion on Hydroxyapatite (nano), 27-28 October 2020, SCCS/1624/2020.
Fichier non déposé

Dates et versions

hal-02996952 , version 1 (09-11-2020)

Identifiants

  • HAL Id : hal-02996952 , version 1

Citer

U. Bernauer, L. Bodin, Q. Chaudhry, P.J. Coenraads, M. Dusinska, et al.. SCCS OPINION ON Hydroxyapatite (nano)". Scientific Committee for Consumer Safety (SCCS / EC). , 2020, Scientific Committee for Consumer Safety (SCCS, EC). ⟨hal-02996952⟩
113 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More